Expression and distribution of carboxypeptidase B in the hippocampal subregions of normal and Alzheimer's disease brain

Acta Biologica Hungarica

Volumn 54, Issue 1, 2003, Pages 55-62

  Papp, Henrietta ^a   Torok I ^b   Matsumoto, A ^c   Enomoto, T ^d   Matsuyama, S ^c   Kasa P ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Elisabeth Hospital   (Hungary)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Carboxypeptidase B; Hippocampus; Neurofibrillary degeneration

Indexed keywords

CARBOXYPEPTIDASE B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOLOGY; REFERENCE VALUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CARBOXYPEPTIDASE B; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; REFERENCE VALUES;

EID: 0037234163     PISSN: 02365383     EISSN: None     Source Type: Journal    
DOI: 10.1556/ABiol.54.2003.1.6     Document Type: Article

References (21)

1. Akiyama, H., Kondo, H., Ikeda, K., Kato, M., McGeer, E L. (2001) Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition. Brain Res. 902, 77-281.
2. Bobinski, M., Wegiel, J., Wisniewski, H. M., Tarnawski, M., Bobinski, M., Reisberg, B., De Leon, M. J., Miller, D. C. (1996) Neurofibrillary pathology - Correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging 17, 909-919.
3. Braak, H., Braak, E. (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural. Transm. 53, 127-140.
4. Brady, D. R., Mufson, E. J. (1991) Alz-50 immunoreactive neurophil differentiates hippocampal complex subfields in Alzheimer's disease. J. Comp. Neurol. 305, 489-507.
5. Fukutani, Y., Kobayashi, K., Nakamura, I., Watanabe, K., Isaki, K., Caims, N. J. (1995) Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci. Lett. 200, 57-60.
6. Gallyas, F. (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad Sci. Hung. 19, 1-8.
7. Haga, C., Ikeda, K., Iwabuchi, K., Akiyama, H., Kondoh, H., Kosaka, K. (1994) Methenamine-silver staining: a simple and sensitive staining method for senile plaques and neurofibrillary tangles. Biotechnic Histochem. 69, 295-300.
8. Iqbal, K., Alonso, A. C., Gong, C. X., Khatoon, S., Pei, J. J., Wang, J. Z., Grundke-Iqbal, I. (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J. Neural. Transm. Suppl. 53, 169-180.
9. 1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
10. Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, C., Hama, E., Lee, H. J., Saido, T. C. (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552.
11. Kása, P., Papp, H., Kása, P. jr, Török, I. (2000) Donepezil dose-dependently inhibit acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 1001, 89-100.
12. Kása, P., Rakonczay, Z., Gulya, K. (1997) The cholinergic system in Alzheimer's disease. Prog. Neurobiol, 52, 511-535.
13. Markesbery, W. R. (1997) Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S13-S19.
14. Matsumoto, A., Itoh, K., Matsumoto, R. (2000) A novel carboxypeptidase B that processes native β-amyloid precursor protein is present in human hippocampus. Eur. J. Neurosci. 12, 227-238.
15. Matsumoto, A., Itoh, K., Seki, T., Motozaki, K., Matsuyama, S. (2001) Human brain carboxypeptidase B, which cleaves β-amyloid peptides in vitro is expressed in the endoplasmic reticulum of neurons. Eur. J. Neurosci. 13, 1653-1657.
16. Matsumoto, A., Motozaki, K., Seki T., Sasaki, R., Kawabe, T. (2001) Expression of human brain carboxypeptidase B, a possible cleaving enzyme for β-amyloid precursor protein, in peripheral fluids. Neurosci. Res. 39, 313-317.
17. Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., Hashimoto, S., Nishimura, T. (1991) Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci. Lett. 130, 195-198.
18. Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., Iwatsubo, T., Saido, T. C. (2001) Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276, 21895-21901.
19. Yamaguchi, H., Haga, C., Hirai, S., Nakazato, Y., Kosaka, K. (1990) Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brain by new methenamine silver stain. Acta Neuropathol. 79, 569-572.
20. Yasojima, K., McGeer, E. G., McGeer, P. L. (2001) Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115-121.
21. Yasojima, K., Akiyama, H., McGeer, E. G., McGeer, P. L. (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci. Lett. 297, 97-100.